NEW YORK, April 3 – Protein chip developer Zyomyx said Tuesday that Raju Kucherlapati has joined its board of directors.
Kucherlapati was a founder of Cell Genesys and Millennium Pharmaceuticals and currently serves as a director for Abgenix, Millennium, and Valentis.
Kucherlapati completed his postdoctoral work at Yale University and was awarded a PhD in genetics from the University of Illinois, Urbana.
Zyomyx of Hayward, Calif., has an agreement with Cambridge Antibody Technology to jointly develop high-density protein chips and is scheduled to begin beta testing its protein chips sometime in the first half of this year.
The privately-held company has raised $32.6 million in private financing.